Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates in osteoporosis.

H Fleisch1

  • 1Av. Désertes 5, 1009, Pully, Switzerland. fleisch@bluewin.ch

European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
|September 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Introduction to bisphosphonates. History and functional mechanisms].

Der Orthopade·2007
Same author

[The water softening action of a medicinal agent. The discovery of a new drug class].

Pharmazie in unserer Zeit·2001
Same author

[Osteoclasts in the reticule. Molecular mechanisms of bisphosphonates].

Pharmazie in unserer Zeit·2001
Same author

Zoledronic acid: an evolving role in the treatment of cancer patients with bone disease.

Seminars in oncology·2001
Same author

Can bisphosphonates be given to patients with fractures?

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2001
Same author

From polyphosphates to bisphosphonates and their role in bone and calcium metabolism.

Progress in molecular and subcellular biology·1999
Same journal

Biokinetic insights into the hip-spine relationship: no correlation between hip strength or flexibility and altered pelvic motion in patients with low back pain.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same journal

UBE-TFD for lumbar foraminal stenosis and extreme lateral disc herniation: a preliminary case series of Doom's Point vs. pars interarticularis localization.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same journal

The reliability and validity of the 30-second chair sit-to-stand test and the five-repetition sit-to-stand test in individuals following lumbar spinal surgery.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same journal

Intraoperative neuromonitoring in degenerative cervical myelopathy surgery: a systematic review and meta-analysis of diagnostic accuracy and postoperative neurological outcomes.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same journal

Radiologic and clinical outcomes of unilateral biportal endoscopic decompression for thoracic ossification of the ligamentum flavum.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same journal

A predictive tool incorporating frailty scores for perioperative risk assessment in patients with spinal metastasis: a national retrospective cohort study.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
See all related articles

Bisphosphonates are effective drugs for treating bone diseases like osteoporosis by inhibiting bone resorption. They reduce bone loss and fractures, with minimal side effects when administered correctly.

Area of Science:

  • Pharmacology
  • Bone Biology
  • Endocrinology

Background:

  • Bisphosphonates are characterized by a P-C-P structure.
  • They primarily target bone tissue, inhibiting bone resorption.
  • This action leads to decreased bone loss and increased bone mineral density.

Purpose of the Study:

  • To review the mechanism of action and clinical applications of bisphosphonates.
  • To highlight their efficacy in treating conditions with high bone turnover.
  • To discuss their role in osteoporosis management and fracture prevention.

Main Methods:

  • Review of pharmacological properties of bisphosphonates.
  • Analysis of clinical studies on bisphosphonate efficacy in bone diseases.
  • Evaluation of safety profiles and administration guidelines.

Related Experiment Videos

Main Results:

  • Bisphosphonates effectively decrease bone loss and turnover.
  • They are proven to reduce both vertebral and nonvertebral fractures in osteoporosis patients.
  • Adverse events are predominantly gastrointestinal and manageable with proper administration.

Conclusions:

  • Bisphosphonates are the leading therapeutic agents for osteoporosis treatment and secondary prevention.
  • Their unique P-C-P structure confers potent bone resorption inhibition.
  • Few alternative treatments offer a comparable efficacy and safety profile.